These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14476315)

  • 1. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.
    PERKINS FT; YETTS R; GAISFORD W
    Br Med J; 1959 Mar; 1(5123):680-2. PubMed ID: 13629087
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization of infants with formalinized poliomyelitis vaccine (Salk type).
    SPIGLAND I; GOLDBLUM N
    Pediatrics; 1960 May; 25():812-21. PubMed ID: 13833339
    [No Abstract]   [Full Text] [Related]  

  • 5. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response and survival following booster injections of poliomyelitis (killed-virus) vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Pediatrics; 1962 Jan; 29():116-20. PubMed ID: 13865768
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the antibody response to basic immunizing treatment carried out with 2 or 3 injections of antipoliomyelitic vaccine (Salk type)].
    SANTOPADRE G; CASAROSA S; RUSCHI A; ZERBONI R
    Riv Ital Ig; 1961; 21():192-204. PubMed ID: 14497064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.
    FLACK A; HUMMELER K; HUNT AD; JERVIS GA; KOPROWSKI H; NORTON TW; STOKES J
    J Am Med Assoc; 1956 Dec; 162(14):1281-8. PubMed ID: 13366742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunization of newborn infants with antipoliomyelitis trivalent oral vaccine].
    CAMPILLO SAINZ C; ORNELAS HERNANDEZ A; DE MUCHA MACIAS J; NAVA SE
    Bol Oficina Sanit Panam; 1962 Aug; 53():130-5. PubMed ID: 13876085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody response to anti-poliomyelitis vaccine (Salk type) in a group of children in the first 4 years of life].
    ODDO FG; FLACCOMIO R; PRIOLO A; SANTAMAURA S
    Riv Ist Sieroter Ital; 1959; 34():225-35. PubMed ID: 14428254
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response of newborns to formalinized poliomyelitis vaccine (Salk type).
    RANNON L; GOLDBLUM N; SKALSKA P; GOTLIEB A
    Am J Hyg; 1960 Sep; 72():244-9. PubMed ID: 13739498
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the responses of 100 infants to primary poliomyelitis immunization with two and with three doses of vaccine.
    PERKINS FT; YETTS R; GAISFORD W
    Br Med J; 1959 Apr; 1(5129):1083-6. PubMed ID: 13638637
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of antibody following booster dose of poliomyelitis vaccine.
    WILSON RJ; MOSS GW; JACOBS JP; MACLEOD DR
    Can J Public Health; 1962 Jan; 53():17-21. PubMed ID: 14007415
    [No Abstract]   [Full Text] [Related]  

  • 16. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.
    SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS
    Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761
    [No Abstract]   [Full Text] [Related]  

  • 18. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 19. The antibody response to poliomyelitis vaccine in school-children at the time of initial vaccination and one year later.
    ARMSTRONG CW; MOSS GW; POTTER FC
    Can J Public Health; 1957 Mar; 48(3):96-100. PubMed ID: 13413743
    [No Abstract]   [Full Text] [Related]  

  • 20. Unpredictability of antibody response of infants to injections of Salk poliomyelitis vaccine.
    CRAMBLETT HG; FOMON SJ
    J Pediatr; 1961 Jun; 58():779-84. PubMed ID: 13696225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.